Medivation Inc (MDVN) Financial Statements (2024 and earlier)

Company Profile

Business Address 525 MARKET STREET
SAN FRANCISCO, CA 94105
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

6/30/2016
MRQ
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 225,853,000502,677,000228,788,000296,240,000
Cash and cash equivalents 225,853,000502,677,000228,788,00071,301,000
Short-term investments    224,939,000
Restricted cash and investments 930,000203,000  
Prepaid expense and other current assets12,175,000
Deferred tax assets  21,987,000  
Other undisclosed current assets 407,435,000197,001,000125,191,00035,801,000
Total current assets: 634,218,000721,868,000353,979,000344,216,000
Noncurrent Assets
Property, plant and equipment 58,142,00041,161,00017,035,00013,262,000
Intangible assets, net (including goodwill) 662,942,000111,000,000
Goodwill 18,643,00010,000,000  
Intangible assets, net (excluding goodwill) 644,299,000101,000,000  
Restricted cash and investments 12,206,00011,562,0009,899,0008,843,000
Other noncurrent assets 7,072,00010,852,00011,737,000
Prepaid expense and other noncurrent assets5,545,000
Deferred tax assets, net 57,011,00015,176,000  
Total noncurrent assets: 797,373,000189,751,00038,671,00027,650,000
TOTAL ASSETS: 1,431,591,000911,619,000392,650,000371,866,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 119,728,00070,063,000184,638,00064,463,000
Interest and dividends payable 305,0001,698,000  
Taxes payable 32,565,0002,106,000  
Employee-related liabilities 29,215,00033,272,00023,832,00013,439,000
Accounts payable 22,696,00010,492,0003,290,0002,073,000
Accounts payable and other accrued liabilities78,758,000 
Accrued liabilities 34,947,00022,495,00078,758,00048,951,000
Business combination, contingent consideration, liability 4,900,00010,000,000
Deferred revenue and credits  2,822,00016,931,00033,862,000
Other undisclosed current liabilities 141,475,00036,767,000(105,880,000)(13,439,000)
Total current liabilities: 266,103,000119,652,00095,689,00084,886,000
Noncurrent Liabilities
Long-term debt and lease obligation  222,140,000208,414,000196,007,000
Long-term debt, excluding current maturities  222,140,000208,414,000196,007,000
Liabilities, other than long-term debt 275,403,000101,827,00017,141,00021,128,000
Deferred revenue and credits    8,465,000
Deferred tax liabilities, net  10,0005,541,0003,800,000
Other liabilities 13,035,0005,817,00011,600,0008,863,000
Business combination, contingent consideration, liability 262,368,00096,000,000
Other undisclosed noncurrent liabilities 17,406,00018,701,000(5,541,000)(3,800,000)
Total noncurrent liabilities: 292,809,000342,668,000220,014,000213,335,000
Total liabilities: 558,912,000462,320,000315,703,000298,221,000
Equity
Equity, attributable to parent 872,679,000449,299,00076,947,00073,645,000
Common stock 1,639,000781,000758,000748,000
Additional paid in capital 684,841,000506,227,000410,350,000364,412,000
Accumulated other comprehensive income    33,000
Retained earnings (accumulated deficit) 186,199,000(57,709,000)(334,161,000)(291,548,000)
Total equity: 872,679,000449,299,00076,947,00073,645,000
TOTAL LIABILITIES AND EQUITY: 1,431,591,000911,619,000392,650,000371,866,000

Income Statement (P&L) (USD)

6/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating expenses (528,645,000)(428,641,000)(295,183,000)(207,910,000)
Other undisclosed operating income 943,258,000710,487,000272,942,000181,696,000
Operating income (loss): 414,613,000281,846,000(22,241,000)(26,214,000)
Nonoperating expense (33,295,000)(21,652,000)(20,257,000)(15,036,000)
Interest and debt expense (21,087,000)(22,851,000)(20,249,000) 
Income (loss) from continuing operations before equity method investments, income taxes: 360,231,000237,343,000(62,747,000)(41,250,000)
Other undisclosed income from continuing operations before income taxes 21,087,00022,851,00020,249,000 
Income (loss) from continuing operations before income taxes: 381,318,000260,194,000(42,498,000)(41,250,000)
Income tax expense (benefit) (136,593,000)16,258,000(115,000)(7,000)
Income (loss) from continuing operations: 244,725,000276,452,000(42,613,000)(41,257,000)
Income (loss) before gain (loss) on sale of properties: 244,725,000276,452,000(42,613,000)(41,257,000)
Net income (loss) available to common stockholders, basic: 244,725,000276,452,000(42,613,000)(41,257,000)
Interest on convertible debt 3,629,00014,030,000  
Net income (loss) available to common stockholders, diluted: 248,354,000290,482,000(42,613,000)(41,257,000)

Comprehensive Income (USD)

6/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss): 244,725,000276,452,000(42,613,000)(41,257,000)
Other comprehensive income (loss)   (33,000)20,000
Comprehensive income (loss), net of tax, attributable to parent: 244,725,000276,452,000(42,646,000)(41,237,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: